Latest

Jun 25, 2018
Steve Gens talks to Pharm Exec about the evolution of Regulatory Information Management (RIM) and offers some predictions for 2022.
Jun 21, 2018
From persistent identity to cloud marketing driven by AI, managing holistic experience is now the hallmark of brand leadership. Croom Lawrence and Kent Groves explains how people-based marketing plays a key role.
Jun 07, 2018
Pressure to assess and approve a growing volume of promising new drugs and biologics in accelerated timeframes is prompting a major reorganization of CDER's Office of New Drugs.
Jun 01, 2018
The PD-1/PD-L1 market in China is heating up and companies there have made a series of advances, writes Jin Zhang.
Jun 01, 2018
Structured authoring is an approach that has eluded life sciences, limiting firms’ ability to transform routine regulatory processes. But this could all change, writes Romuald Braun.
May 31, 2018
Digital health is not at all about the app. It’s about the behavior of the individual patient, said Søren Smed Østergaard at this year's Digital Health World Congress in London.
May 25, 2018
Pharmaceutical Executive
In this demanding environment, yesterday’s product launch playbook can no longer be relied upon to yield the expected patient or business outcomes, writes Boris Bogdan.
May 23, 2018
Right-to-Try bill sent to White House for President’s signature after passage by Congress.
May 23, 2018
Pharmaceutical Executive
A discussion of the benefits that a cloud-based strategy has to offer.
May 18, 2018
Pharmaceutical Executive
By Pharmaceutical Executive Editors
This article is a roundtable consisting of global Medical Affairs leaders to discuss the potential of Medical Affairs as a key value driver and the role MAPS will play in bringing that potential to fruition.
native1_300x100
lorem ipsum